RNAi for Pathway Analysis 2006
PRE-CONFERENCE EVENTS

Tuesday, January 31

3:30-6:00pm Tutorial (separate registration is required)
More Effective RNAi Studies with High-Content Screening
Mr. Joseph A. Zock, Senior Manager, HCS User Services, Cellomics, Inc.
The promise of using RNAi to deconvolve complex signaling pathways and cellular processes requires detection methods robust enough to deal with variability in transfection frequency and percent knockdown. High-Content Screening (HCS) technology is uniquely suited to this goal by quantitatively measuring multiple target intensity and morphology changes in individual cells of a given experimental population. The combination of HCS and RNAi provides a powerful platform for drug discovery. In this tutorial session you will learn the basics of HCS, how it works, and what unique features are being used to gather more effective data from RNAi experiments. We will also touch on analysis of RNAi effects, both primary and off-target, using multiple HCS endpoints.

Co-Located at High-Content Analysis 2006

8:00am–3:00pm Cellomics User Group Meeting 
This user group meeting will be a forum for you to interact with other scientists who are using HCS as a tool for furthering their discovery efforts. Submit an abstract to present what your laboratory is doing with HCS, or attend to learn how your colleagues are optimizing their HCS experience. We will have oral and poster presentations by leading scientists in the industry. All Cellomics customers are welcome to attend. For more information on this event or to register to attend, please contact us at usergroup@cellomics.com or visit our User Group Web site at www.cellomics.com/usergroup/site/sf05_usergroup/index.html.
RNAi for Pathway Analysis 2006

3:00-7:00pm High Content Analysis End-User Forum

Overcoming technical Challenges in HCA Implementation

Participation is limited to end-users only and subject to approval by conference organizers. Companies with HCA-relatedproducts or services on the market or in development (including sponsoring and exhibiting companies) will not receive access tothe End-User Forum. Separate registration is required. Dinner is included.

5:00-7:00pm Conference Pre-Registration

For more information please contact: 
Julia Boguslavsky, Conference Director, Cambridge Healthtech Institute
Phone: 781-972-5482 or E-mail: juliab@healthtech.com

For exhibit and sponsorship information, please contact:
Carol Dinerstein, Manager, Business Development
Phone: 781-972-5471 • E-mail: dinerstein@healthtech.com